Immunoassay market is expected to grow at a considerable rate during the forecast period 2019-2025. Immunoassay is performed to check or confirm the presence and amount of specific substance/proteins in the solution through the use of an antibody or an antigen. It is a biochemical test for quick and accurate diagnosis. The test is performed with antigens and antibodies to react with the solution. Immunoassays are being used in laboratory research, hospitals, and pharmaceutical companies. The test provides bio information about the severity or degree of illness by diagnosing concentration of molecules in the human body. Bio information received is used to plan better treatment and further prevention. Drug discovery is one of the major application areas for immunoassays. Due to the growing number of diseases, demand is increasing for drugs of particular diseases.  Immunoassays aid in bioanalysis of various diseases and drug development. Therapeutic drug monitoring and clinical pharmacokinetic are other major application areas for immunoassays.

Global immunoassay market is segmented on the basis of product and technology. On the basis of the product, the market is segmented into the analyzer and consumable. The consumable segment is estimated to grow with a substantial rate during the forecast period due to the growing need for drug development and diagnosis with the increasing number of chronic diseases. Analyzer market is estimated to hold a major share of the global immunoassay market. On the basis of technology, the market is diversified into radioimmunoassay, counting immunoassay, enzyme immunoassays, fluoroimmunoassay, and chemiluminescence immunoassay.

In the geographic overview, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America is reporting the dominant share in the global immunoassay market and is estimated to retain market dominance in the forecast period. North America is holding the major market share due to the growing number of biotechnology research projects.  Well-established research and the pharmaceutical industry are other major reasons attributing to the significant share of North America in the global immunoassay market. Asia-Pacific is anticipated to grow with the highest rate due to the growing geriatric population and an increasing number of chronic diseases among people in the region. Growing investment in pharmaceutical and biotechnology research is estimated to grow the market share substantially during the forecast period. Europe is holding a significant market share in the global immunoassay market. Developing advanced technology in the diagnosis and treatment is propelling the European countries to hold substantial market share. The market comprises of various major players which include Abbott Laboratories, Inc., BioMérieux, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer, Inc., and others.

Research methodology:

The market study of the global Immunoassay market is incorporated by extensive primary and secondary research conducted by a research team at OMR.  Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

• Financial reports of companies involved in the market
• Authentic Public Databases such as the WHO and American Cancer Society.
• Whitepapers, research-papers and news blogs
• Company websites and product catalog.

The report is intended for biotechnology companies, research organizations, companies working on advanced technology, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market segmentation:

1. Global Immunoassay Market Research and Analysis by Product
2. Global Immunoassay Market Research and Analysis by Technology

The report covers:

• Comprehensive research methodology of the global immunoassay market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global immunoassay market.
• Insights about market determinants which are stimulating the global immunoassay market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.